Iptacopan hydrochloride

Iptacopan hydrochloride monohydrate is the monohydrate form of iptacopan hydrochloride. It is a complement factor B inhibitor approved for the treatment of adults with paroxysmal nocturnal hemoglobinuria. Among its listed roles, it functions as a complement factor B inhibitor and an immunomodulator. It includes a iptacopan hydrochloride. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Iptacopan hydrochloride monohydrate and LNP023 hydrochloride monohydrate. Its PubChem CID is 156613702.

CAS No 2447007-60-3
Molecular Formula C25H33ClN2O5
Molecular Weight 477.0 g/mol
Synonyms 4-[(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-2-yl]benzoic acid;hydrate;hydrochloride

Frequently Asked Questions